By

The U.S. Food and Drug Administration today approved Avycaz (ceftazidime-avibactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI), in combination...

By

The U.S. Food and Drug Administration today approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Multiple myeloma is a form of blood cancer that arises from plasma cells,...

By

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis...

By

The U.S. Food and Drug Administration today granted approval to Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive...

By

Anti-infective and oncology pharmaceutical company, Venus Remedies Limited, announced Monday it received a product patent grant for its unique research product, Vancoplus from the Indian Patent Office....

By

The U.S. Food and Drug Administration today expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME). Diabetic...

By

The U.S. Food and Drug Administration today granted accelerated approval to Ibrance (palbociclib) to treat advanced (metastatic) breast cancer. Breast cancer in women is the second most common type of...

By

On January 29, 2015, FDA approved Evotaz, a fixed dose combination tablet containing 300 mg of atazanavir and 150 mg of cobicistat. Evotaz is indicated in combination with other antiretroviral agents for...

On the heels of President Obama’s announcement to increase spending on antibiotic resistance to $1.2B, researchers from Tel Aviv University (TAU) have shown that proteins embedded in bacteria by bacteriophages...

Naegleria fowleri, or the “brain-eating amoeba”, is a free living parasite that causes a relatively rare, nearly 100 percent fatal disease in humans called primary amoebic meningoencephalitis...